Diabetes drug tirzepatide recommended to treat obesity on the NHS

4 June 2024

Getty/Deepak Verma

By Storm Newton, PA Media

The type 2 diabetes drug Mounjaro has been recommended to help obese people lose weight on the NHS.

Mounjaro – also known as tirzepatide and made by Eli Lilly – is a glucagon-like peptide-1 (GLP-1) agonist.







Log in or join for free to read more

You might also like